Ingelise Saunders
Chief Executive Officer at iSD Immunotech ApS
Network origin in Ingelise Saunders first degree
Entity | Entity type | Industry | |
---|---|---|---|
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark.
11
| Holding Company | Medical Specialties | 11 |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark.
6
| Holding Company | Biotechnology | 6 |
SLS Invest AB
1
| Private Company | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ingelise Saunders via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
DFDS A/S | Marine Shipping | Chairman | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lauritzen Fonden
Lauritzen Fonden Investment Trusts/Mutual FundsMiscellaneous Lauritzen Fonden operates as an enterprise foundation supporting non-profit activities. It collaborates with public sectors, civic society, non-profit organizations, associations, and other foundations in realizing its vision for youth, children, and charitable initiatives. The company was founded by Ivar Lauritzen, Knud Lauritzen, and Anna Lønberg-Holm in 1945 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
Absolut Co. AB
Absolut Co. AB Beverages: AlcoholicConsumer Non-Durables Absolut Co. AB produces and distributes wine and alcoholic beverages. The company operates in three segments such as the Absolut Spirits, Distillers and Wine. The Absolut Spirits segment produces and markets its products under the Absolut Vodka, Plymouth Gin, Cruzan Rum and Fris Vodka brand names. The Distillers segment engages in the production and sale of spirits under various brands including Aalborg Akvavit, Explorer Vodka, Gammel Dansk, Gronstedts Cognac and Luksusowa. The Wine segment produces and sells table wines, sparkling wines, fortified wines and fruit based wines. The company was founded in 1917 and is headquartered in Stockholm, Sweden. | Beverages: Alcoholic | Corporate Officer/Principal | |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Technical University of Denmark | College/University | Graduate Degree Masters Business Admin | |
University of Lund | College/University | Corporate Officer/Principal | |
University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
Radboud University Nijmegen | College/University | Doctorate Degree | |
University of Southern Denmark | College/University | Graduate Degree | |
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | President | |
DESMI A/S
DESMI A/S Industrial MachineryProducer Manufacturing DESMI A/S develops, manufactures and sells pumps and pumping systems. It supplies products to the marine and offshore related sectors, public utilities and industrial purposes. The company also supplies gearboxes, transmission elements and equipment for combating oil spills. It has offices in Aalborg, Odense, Århus, Copenhagen, Kolding and Sakskøbing. The company was founded in 1875 and is headquartered in Nørresundby, Denmark. | Industrial Machinery | Director/Board Member | |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst | |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Meabco Holding A/S
Meabco Holding A/S MiscellaneousMiscellaneous Meabco Holding A/S operates as a holding company with interest in oncology and radiation protection services. The company was founded in 2008 and is headquartered in Kastrup, Denmark. | Miscellaneous | Director/Board Member | |
Oncorel AB
Oncorel AB Miscellaneous Commercial ServicesCommercial Services Oncorel AB provides medical research services. It pertains to develop anti-cancer treatment. The company was founded in 2009 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Durisol UK
Durisol UK Construction MaterialsNon-Energy Minerals Durisol UK is a private company that specializes in manufacturing and selling cement-bonded wood fibre products. The company is based in Gwent, UK. | Construction Materials | Director/Board Member | |
Fonden Kattegat Silo | Chairman | ||
Kommanditaktieselskabet Østre Havn
Kommanditaktieselskabet Østre Havn Real Estate DevelopmentFinance Kommanditaktieselskabet Østre Havn is a private company based in Aalborg, Denmark. The Danish company provides commercial real estate leasing services. The CEO of the company is Morten Tousgaard. | Real Estate Development | Director/Board Member | |
Royal Arctic Line A/S | Director/Board Member | ||
Invest Brazil A/S | Chairman | ||
Comenxa A/S | Director/Board Member | ||
Mama Mia Holding A/S
Mama Mia Holding A/S Financial ConglomeratesFinance Mama Mia Holding A/S provides financial intermediation services. | Financial Conglomerates | Director/Board Member | |
Million Brains A/S | Director/Board Member | ||
Intelligent Building System Ltd.
Intelligent Building System Ltd. Miscellaneous Commercial ServicesCommercial Services Intelligent Building System Ltd. provides business support services. The private company is based in Glasgow, UK and was founded in 2005. | Miscellaneous Commercial Services | Director/Board Member | |
Østre Havn Aalborg ApS | Director/Board Member | ||
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Withfonden | Director/Board Member | ||
ACOUSORT AB | Medical Distributors | Director/Board Member | |
AHK nr. 186 ApS | Director/Board Member | ||
IDCD ApS | Director/Board Member | ||
Jens Og Margrethe Withs Fond | Investment Trusts/Mutual Funds | Director/Board Member | |
Meabco A/S
Meabco A/S Pharmaceuticals: MajorHealth Technology Meabco A/S is a privately held oncology Danish biotechnology company established in 2001. Meabco is based in Copenhagen, DK. The company develops breakthrough cancer therapy products to significantly improve life with cancer. The company was founded in 2001 by Stig Løfberg, who has been the CEO since then. | Pharmaceuticals: Major | Chairman | |
Lauritzen Fonden Holding ApS
Lauritzen Fonden Holding ApS BiotechnologyHealth Technology LF Investment ApS invests in small and innovative companies within biotechnology and cancer research, shipping, transportation, and logistics. The company was founded in 1900 and is headquartered in Hellerup, Denmark. | Biotechnology | Chief Executive Officer | |
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Århus Universitetshospital
Århus Universitetshospital Hospital/Nursing ManagementHealth Services Aarhus Universitetshospital is a highly specialized hospital located in Aarhus, DK. Aarhus Universitetshospital has been named Denmark's best hospital several times and is known for its specialized medical services. The hospital has subsidiaries in Denmark. The Danish company was founded in 2011, and Poul Blaabjerg has been the CEO of the company since 2017. | Hospital/Nursing Management | Corporate Officer/Principal | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BOMILL AB | Packaged Software | Director/Board Member | |
Bomill Holding AB | Director/Board Member | ||
HepaRegeniX GmbH
HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Hexagem AB
Hexagem AB Electronic Production EquipmentElectronic Technology Hexagem AB offers devices for radio frequency (RF) applications. It develops gallium nitride wafers for RF Electronics. The company was founded by Björn Jonas Ohlsson, Lars Ivar Samuelson, and Albert Joseph Markus on December 7, 2015 and is headquartered in Hjärup, Sweden. | Electronic Production Equipment | Director/Board Member | |
Aduro Biotech Holdings Europe BV
Aduro Biotech Holdings Europe BV BiotechnologyHealth Technology Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands. | Biotechnology | Founder |
Statistics
International
Denmark | 32 |
Sweden | 11 |
United Kingdom | 4 |
Netherlands | 4 |
United States | 2 |
Sectoral
Health Technology | 16 |
Consumer Services | 7 |
Commercial Services | 6 |
Miscellaneous | 4 |
Finance | 4 |
Operational
Director/Board Member | 127 |
Corporate Officer/Principal | 29 |
Chairman | 23 |
Chief Executive Officer | 14 |
Private Equity Investor | 14 |
Most connected contacts
- Stock Market
- Insiders
- Ingelise Saunders
- Company connections